Genetically Modified Parasitic Worms Can Produce Medicines Inside Living Organisms

Scientists have found that genetically modified intestinal worms are capable of producing antibodies directly inside the host organism. In a new study, the parasites partially neutralized the effect of one of the world's most potent toxins, opening the door to an entirely new method of drug delivery.

Parasites have throughout history been primarily disease-causing agents, but a new scientific breakthrough challenges this understanding. In a new study, genetically modified intestinal worms were able to produce and release antibodies directly from within the host organism-a discovery that could one day transform how doctors treat chronic diseases.

From Parasite to Medicine Factory

Researchers modified the genome of intestinal worms so that the parasites began producing specific antibodies in the host's intestines. These antibodies were able to partially neutralize the effect of one of the world's most potent toxins. According to the scientists, this fundamentally demonstrates that a parasite placed inside a living organism can be used as a biological drug factory.

Why This Approach Is Promising

Current biological drugs, such as antibodies, often require regular injections or infusions because they are broken down rapidly in the body. A parasite-based system would theoretically enable continuous, on-site drug production without the patient having to visit the doctor repeatedly. This would be particularly valuable in the treatment of difficult-to-treat chronic diseases.

Scientists acknowledge that the method faces many obstacles before clinical application, including questions of safety, dose control, and immune response. However, the study results indicate that genetically modified parasites could be a promising platform for next-generation drug delivery methods.